If you want different results, do not do the same things

Albert Einstein

Nanokide Therapeutics is a biotechnology company focused on the development of novel antimetastatic solutions based on the combination of nanotechnology and microRNA and mRNA.

Our nanosystems is a flexible, non-toxic and easy to produce formulation that combined with microRNA and mRNA sequences offer a perfect platform for anticancer drugs development.

Isabel Rial

CEO and Founder

PhD in Pharmacy / Researcher

Iker Badiola


PhD in Biology / Assistant professor in UPV/EHU

Majid Khatib


PhD in Biology/ INSERM

The core of our technology is the combination of a flexible nanosystem with microRNA and mRNA therapy against cancer.
The nanosystem developed by Nanokide is based on sorbitan ester.

NIH grants Nanokide

The NCL has selected our technology Span-based nanoparticles loaded with miR-20a for the preclinical development program

Read More

Toribio Echevarria Awards

Nanokide has been awarded as a finalist in the Business Ideas/Projects section of the Toribio Echevarria 2022 awards.

Read More

Cantábrico Excelente Awards

Nanokide Therapeutics has been nominated in the category of best R+D+i company in the VI edition of the Cantabrian Excellent Awards.

Read More

"Our nanoparticle blocks tumor growth"

Interview in the newspaper Berria

Read More

Finalist Toribio Echevarria Awards 2022

Nominated Cantábrico de Excelencia Award 2022


  • Ed. Rectorado – Planta baja Campus de Bizkaia. Sarriena s/n. 48940 Leioa

Videos, images and gifs made by Rosario García Hernández